Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-25-049876
Filing Date
2025-11-06
Accepted
2025-11-06 07:43:46
Documents
17
Effectiveness Date
2025-11-06

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8xq32025.htm S-8 86889
2 exfilingfees.htm   iXBRL EX-FILING FEES 39359
3 EX-5.1 a51opinionforms-8xcrescent.htm EX-5.1 36935
4 EX-23.1 exhibit-231xsx8pwcconsent.htm EX-23.1 1411
5 EX-99.2 a992crescent-stockoptiongr.htm EX-99.2 48576
6 EX-99.3 a993crescent-optionawardag.htm EX-99.3 50782
7 image_2.jpg GRAPHIC 13271
  Complete submission text file 0001628280-25-049876.txt   432689

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 15989
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291307 | Film No.: 251456213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)